Progress to achieve balanced state policy relevant to pain management and palliative care: 2000-2003

Journal of Pain and Palliative Care Pharmacotherapy

Volumn 19, Issue 1, 2005, Pages 13-26

  Gilson, Aaron M ^a,b   Joranson, David E ^a   Maurer, Martha A ^a   Ryan, Karen M ^a   Garthwaite, Jody P ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b Pain and Policy Studies Group   (United States)

Author keywords

Evaluation; Law; Methodology; Pain; Palliative care; Policy; Regulation; Report card

Indexed keywords

NARCOTIC AGENT; OPIATE;

CONFIDENTIALITY; DRUG LEGISLATION; ETHICS; GOVERNMENT; HEALTH CARE; HEALTH CARE ORGANIZATION; HEALTH CARE PERSONNEL; HEALTH CARE POLICY; HEALTH CARE QUALITY; HEALTH PROGRAM; HUMAN; INTERPERSONAL COMMUNICATION; LAW ENFORCEMENT; LEGAL ASPECT; MEDICAL PRACTICE; MEDICAL RESEARCH; MEDICOLEGAL ASPECT; PAIN; PALLIATIVE THERAPY; PATIENT CARE; PRACTICE GUIDELINE; PRESCRIPTION; REVIEW; RISK ASSESSMENT; TIME SERIES ANALYSIS;

DRUG AND NARCOTIC CONTROL; HEALTH POLICY; HUMANS; LAW ENFORCEMENT; PAIN; PALLIATIVE CARE; POLICE; STATE GOVERNMENT; SUBSTANCE-RELATED DISORDERS;

EID: 17844395939     PISSN: 15360288     EISSN: None     Source Type: Journal    
DOI: 10.1300/J354v19n01_05     Document Type: Review

References (51)

1. Arnold R, Berger A, Billings JA, et al. Clinical Practice Guidelines for Quality Palliative Care. Brooklyn, NY: National Consensus Project for Quality Palliative Care; 2004. (Available at http://www.nationalconsensusproject.org/ guideline.pdf)
2. American Academy of Pain Medicine and American Pain Society. The Use of Opioids for the Treatment of Chronic Pain: A Consensus Statement. Glenview, IL: American Academy of Pain Medicine and American Pain Society; 1997. (Available at http://www.painmed.org/productpub/statements/oploidstmt.html)
3. World Health Organization Cancer and Palliative Care Unit. Cancer Pain Relief: A Guide to Opioid Availability. WHO Collaborating Center for Symptom Evaluation in Cancer Care; Madison. Wisconsin. USA. 1992 (Monograph).
4. Noah L. Challenges in the federal regulation of pain management technologies. J Law Med Ethics. 2003; 31(1):55-74.
5. Gilson AM, Joranson DE. U.S. policies relevant to the prescribing of opioid analgesics for the treatment of pain in patients with addictive disease. Clin J Pain. 2002; 18(4 suppl):S91-S98. (Available at http://www.medsch.wisc. edu/painpolicy/publicat/02cjpn/index.htm)
6. International Narcotics Control Board. Report of the International Narcotics Control Board for 1995: Availability of Opiates for Medical Needs. New York, NY: United Nations; 1996. (Available at http://www.incb.org/e/ind_ar.htm)
7. World Health Organization. Achieving Balance in National Opioids Control Policy: Guidelines for Assessment. Geneva, Switzerland: World Health Organization; 2000. (Available at http://www.medsch.wisc.edu/painpolicy/ publicat/00whoabi/00whoabi.htm)
8. Institute of Medicine Committee on Opportunities in Drug Abuse Research. Pathways of Addiction: Opportunities in Drug Abuse Research. Washington, DC: National Academy Press; 1996. (Available at http://www.nap.edu/catalog/5297. html)
9. Institute of Medicine Committee on Care at the End of Life. Approaching Death: Improving Care at the End of Life. Washington, DC: National Academy Press; 1997. (Available at http://books.nap.edu/catalog/5801.html)
10. American Medical Association-House of Delegates. Protection for Physicians Who Prescribe Pain Medication H-120.960. Chicago, IL: American Medical Association: 2003.
11. Cancer Pain Management Policy Review Group. American Cancer Society Position Statement on Regulatory Barriers to Quality Cancer Pain Management. National Government Relations Department, American Cancer Society; 2001.
12. National Institutes of Health Consensus Development Program. Symptom Management in Cancer: Pain, Depression and Fatigue. Statement prepared following a National Institutes of Health State-of-the-Science Conference on Symptom Management in Cancer; Bethesda, MD; July 15-17, 2002. (Available at http://consensus.nih.gov/ta/022/022_intro.htm)
13. National Association of Attorneys General. Improving End-of-Life Care: The Role of Attorneys General. Edmondson WAD, editor. Washington, DC: National Association of Attorneys General; 2003.
14. Federation of State Medical Boards of the United States Inc. Model Policy for the Use of Controlled Substances for the Treatment of Pain. Dallas, TX: Federation of State Medical Boards of the United States Inc.; 2004. (Available at http://www.fsmb.org)
15. Gilson AM, Joranson DE. Controlled substances and pain management: Changes in knowledge and attitudes of state medical regulators. J Pain Symptom Manage. 2001; 21(3):227-237. (Available at http://www.medsch.wisc.edu/ painpolicy/publicat/01jpsm/index.htm)
16. Gilson AM, Joranson DE, Maurer MA. Improving state medical board policies: Influence of a model. J Law Med Ethics. 2003; 31(1):119-129. (Available at http://www.medsch.wisc.edu/painpolicy/publicat/03jlme/index.htm)
17. Joranson DE, Gilson AM, Dahl JL, Haddox JD. Pain management, controlled substances, and state medical board policy: A decade of change. J Pain Symptom Manage. 2002; 23(2): 138-147. (Available at http://www.medsch.wisc.edu/ painpolicy/publicat/02jpsm1/index.htm)
18. Joranson DE, Gilson AM, Nischik JA. North Carolina, pain management and end-of-life care: Communicating the policy. Fed Bull, J Med Licen & Disc. 2002; 88(3): 116-119. (Available at http://www.medsch.wisc.edu/painpolicy/ publicat/02fsmb/index.htm)
19. Medical Board of California. New, easy guidelines on prescribing. Action Report. 1994; 51:1,8.
20. Federation of State Medical Boards of the United States Inc. Model Guidelines for the Use of Controlled Substances for the Treatment of Pain. Euless, TX: Federation of State Medical Boards of the United States Inc; 1998. (Available at http://www.fsmb.org)
21. Federation of State Medical Boards of the United States Inc. Position of the Federation of State Medical Boards in support of adoption of pain management guidelines. 2000.
22. Joranson DE, Gilson AM, Ryan KM, et al. Achieving Balance in Federal and State Pain Policy: A Guide to Evaluation. Madison, WI: Pain & Policy Studies Group, University of Wisconsin Comprehensive Cancer Center; 2000. (Available at http://www.medsch.wisc.edu/painpolicy/eguide2000/index.html)
23. Pain & Policy Studies Group. Achieving Balance in Federal and State Pain Policy: A Guide to Evaluation, Second Edition. Madison, WI: University of Wisconsin Comprehensive Cancer Center; 2003. (Available at http://www.medsch. wisc.edu/painpolicy/2003_balance/)
24. Dahl JL, Joranson DE. Cancer pain: the US responds. Palliat Med. 1992; 6:94-97.
25. Dahl JL, Joranson DE, Weissman DE. The Wisconsin cancer pain initiative: a progress report. Am J Hospice Care. 1989; 6(6):39-43.
26. National Conference of Commissioners on Uniform State Laws. Uniform Controlled Substances Act. NCCUSL; Chicago, IL. Adopted at its Annual Conference Meeting in its One-Hundred-and-Third-Year; Chicago, IL; July 29-August 5, 1994.
27. Controlled Substances Act. Pub L No. 91 -513,84 Stat 1242, 1970.
28. Controlled Substances Act. Title 21 USC §801(1). (Available at http://www.deadiversion.usdoj.gov/21cfr/21usc/21iausct.htm)
29. Joranson DE, Gilson AM. Controlled substances, medical practice, and the law. In: Schwartz HI, ed. Psychiatric Practice Under Fire: the Influence of Government, the Media, and Special Interests on Somatic Therapies. 1st ed. Washington DC: American Psychiatric Press, Inc.; 1994:173-194. (Available at http://www.medsch.wisc.edu/painpolicy/publicat/94appcs.htm)
30. Joranson DE. Federal and state regulation of opioids. J Pain Symptom Manage. 1990; 5(Suppl.)(1):S12-S23. (Available at http://www.medsch.wisc.edu/ painpolicy/publicat/90jpsmf.htm)
31. Last Acts. Means to a Better End: A Report on Dying in America Today. Washington, DC: Last Acts National Program Office: 2002. (Available at http://www.lastacts.org/)
32. Pain & Policy Studies Group. Achieving Balance in State Pain Policy: A Progress Report Card. Madison, WI: University of Wisconsin Comprehensive Cancer Center; 2003. (Available at http://www.medsch.wisc.edu/painpolicy/ 2003_balance/)
33. Dahl JL, Bennett ME, Bromley MD, Joranson DE. Success of the State Pain Initiatives. Cancer Pract. 2002; 10(Suppl. 1):S9-S13. (Available at http://www.aacpi.wisc.edu/images/SPI.pdf)
34. Drug Enforcement Administration, Last Acts, Pain & Policy Studies Group, et al. Promoting Pain Relief and Preventing Abuse of Pain Medications: A Critical Balancing Act. Washington, DC: Last Acts: 2001. (Available at http://www.medsch.wisc.edu/painpolicy/dea01.htm)
35. Hoffmann DE, Tarzian AJ. Achieving the right balance in oversight of physician opioid prescribing for pain: The role of state medical boards. J Law Med Ethics. 2003; 31(1):21-40. (Available at http://www.aslme.org/pub_jlme/ index_31.php)
36. United Nations. Single Convention on Narcotic Drugs, 1961. Geneva, Switzerland: United Nations; 1973.
37. Federation of State Medical Boards of the United States Inc. A Guide to the Essentials of a Modern Medical Practice Act. 9th ed. Dallas, TX: Federation of State Medical Boards; 2000. (Available at http://www.fsmb.org/)
38. American Alliance of Cancer Pain Initiatives. Statement on State Prescription Monitoring Programs. Madison, WI: AACPI: 2002. (Available at http://www.aacpi.wisc.edu/regulatory/regulatory.html)
39. Brushwood DB. Maximizing the value of electronic prescription monitoring programs. J Law Med Ethics. 2003; 31(1):41-54. (Available at http://www.aslme.org/mayday.php)
40. American Alliance of Cancer Pain Initiatives. Statement on Intractable Pain Treatment Acts (IPTA). Madison, WI: AACPI; 2004.
41. Hawryluck LA, Harvey WRC, Lemieux-Charles L, Singer PA. Consensus guidelines on analgesia and sedation in dying intensive care unit patients. BMC Med Ethics. 2002; 3:1-9. (Available at http://www.biomedcentral.com/1472-6939/3/ 3)
42. Institute of Medicine National Cancer Policy Board. Improving Palliative Care for Cancer. Foley KM, Gelband H, editors. Washington, DC: National Academy Press; 2001. (Available at http://www.nap.edu/catalog/10149.html)
43. Meisel A, Snyder L, Quill T. Seven legal barriers to end-of-life care: Myths, realities, and grains of truth. JAMA. 2000; 284(19):2495-2501.
44. Zerzan J, Stearns S, Hanson L. Access to palliative care and hospice in nursing homes. JAMA. 2000; 284(19):2489-2494.
45. Dahl JL. Working with regulators to improve the standard of care in pain management: The U.S. experience. J Pain Symptom Manage. 2002; 24(2):136-146.
46. Ferrante FM. Principles of opioid pharmacotherapy: practical implications of basic mechanisms. J Pain Symptom Manage. 1996; 11(5):265-273.
47. Furstenberg CT, Ahles TA, Whedon MB, et al. Knowledge and attitudes of health-care providers toward cancer pain management: a comparison of physicians, nurses, and pharmacists in the State of New Hampshire. J Pain Symptom Manage. 1998; 15(6):335-349.
48. Drug Enforcement Administration, Last Acts, Pain & Policy Studies Group. Prescription Pain Medications: Frequently Asked Questions and Answers for Health Care Professionals and Law Enforcement Personnel. Washington, DC: Drug Enforcement Administration; 2004. (Available at http://www.deadiversion.usdoj. gov/faq/pain_meds_faqs.pdf)
49. Gregoire CO. When the law is good medicine. J Law Med Ethics. 2002; 30(3):41-44.
50. Ziegler SJ, Lovrich NP. Pain relief, prescription drugs, and prosecution: a four-state survey of chief prosecutors. J Law Med Ethics. 2003; 31(1):75-100.
51. Passik S. Letter to the Editor: Same as it ever was? Life after the Oxycontin Media Frenzy. J Pain Symptom Manage. 2003; 25(3):199-201.